Clinical Research

Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer?

Volume: 15 Number: 3 May 25, 2021
EN TR

Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer?

Abstract

Background: In infertility clinics, biopsies taken from undescended atrophic testicles showed increased mast cells which are not found in normal testis. So, it was thought that mast cells could have a contributing effect on fibrosis leading to testicular atrophy. Our aim of the study is to investigate the efficacy of ketotifen, which is a mast cell stabilizer, on the prevention of testicular fibrosis in a testicular torsion-detorsion rat model.

Materials and Methods: Thirty rats were divided into three equal groups, each consisting of ten animals. In group A; the testicular tissues were only separated from the gubernaculum without torsion (Sham). In group B, detorsion was performed after four hours of testicular torsion in the right testes. In group C, after four hours of right testicular torsion and detorsion, the rats were taken ketotifen as a medical treatment (1 mg/kg/day, orally started on the first day, continued for three weeks). The rats were sacrificed under anesthesia, three weeks after surgery to determine testicular fibrosis. Histopathologic evaluation was performed with Johnsen's score in both testes as a control evaluation.

Results: According to Johnsen score, median values were found 9.9 in group A; 3.7 in group B, and 8.4 in group C. Johnsen score was found significantly high in group C (with ketotifen) when compared with the other groups (p< 0.05). When we made a pairwise comparison, we found a significant difference between the group's A and B (p=0.0001), the group’s B and C; (p=0.039), and the group’s A and C (p=0.006). Conclusion: We found that ketotifen had a preventing effect against testicular fibrosis as a mast cell stabilizer in the testis torsion-detorsion rat model.

Keywords

References

  1. 1. Wynn, T.A. and T.R. Ramalingam, Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med, 2012. 18(7): p. 1028-40.
  2. 2. Mechlin, C.W., et al., Mast cell numbers negatively correlate with fibrosis in cryptorchid testes. J Pediatr Urol, 2014. 10(3): p. 527-31.
  3. 3. Bradding, P. and G. Pejler, The controversial role of mast cells in fibrosis. Immunol Rev, 2018. 282(1): p. 198-231.
  4. 4. Acer-Demir, T., et al., The long term effects of intrascrotal low dose and high dose N-acetylcysteine on testis damage in rat model of testicular torsion. J Pediatr Surg, 2020. 55(4): p. 672-680.
  5. 5. Moreno, D., et al., Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord. Asian J Androl, 2020. 22(1): p. 112-117.
  6. 6. AZILI, M.N., et al., Effects of Captopril and Ketotifen on Protecting Against Renal Scarring Due to Pyelonephritis Injury.
  7. 7. Welter, H., et al., Angiotensin II regulates testicular peritubular cell function via AT1 receptor: a specific situation in male infertility. Mol Cell Endocrinol, 2014. 393(1-2): p. 171-8.
  8. 8. Garbuzenko, E., et al., Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy, 2002. 32(2): p. 237-46.

Details

Primary Language

English

Subjects

Surgery

Journal Section

Clinical Research

Publication Date

May 25, 2021

Submission Date

April 14, 2021

Acceptance Date

May 3, 2021

Published in Issue

Year 2021 Volume: 15 Number: 3

APA
Azılı, M., Germen Ünverdi, H., Hücümenoğlu, S., & Tiryaki, T. (2021). Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer? Türkiye Çocuk Hastalıkları Dergisi, 15(3), 234-238. https://doi.org/10.12956/tchd.915322
AMA
1.Azılı M, Germen Ünverdi H, Hücümenoğlu S, Tiryaki T. Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer? Turkish J Pediatr Dis. 2021;15(3):234-238. doi:10.12956/tchd.915322
Chicago
Azılı, Müjdem, Hatice Germen Ünverdi, Sema Hücümenoğlu, and Tuğrul Tiryaki. 2021. “Can Testicular Fibrosis Due to Testicular Torsion Be Prevented With Ketotifen As A Mast Cell Stabilizer?”. Türkiye Çocuk Hastalıkları Dergisi 15 (3): 234-38. https://doi.org/10.12956/tchd.915322.
EndNote
Azılı M, Germen Ünverdi H, Hücümenoğlu S, Tiryaki T (May 1, 2021) Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer? Türkiye Çocuk Hastalıkları Dergisi 15 3 234–238.
IEEE
[1]M. Azılı, H. Germen Ünverdi, S. Hücümenoğlu, and T. Tiryaki, “Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer?”, Turkish J Pediatr Dis, vol. 15, no. 3, pp. 234–238, May 2021, doi: 10.12956/tchd.915322.
ISNAD
Azılı, Müjdem - Germen Ünverdi, Hatice - Hücümenoğlu, Sema - Tiryaki, Tuğrul. “Can Testicular Fibrosis Due to Testicular Torsion Be Prevented With Ketotifen As A Mast Cell Stabilizer?”. Türkiye Çocuk Hastalıkları Dergisi 15/3 (May 1, 2021): 234-238. https://doi.org/10.12956/tchd.915322.
JAMA
1.Azılı M, Germen Ünverdi H, Hücümenoğlu S, Tiryaki T. Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer? Turkish J Pediatr Dis. 2021;15:234–238.
MLA
Azılı, Müjdem, et al. “Can Testicular Fibrosis Due to Testicular Torsion Be Prevented With Ketotifen As A Mast Cell Stabilizer?”. Türkiye Çocuk Hastalıkları Dergisi, vol. 15, no. 3, May 2021, pp. 234-8, doi:10.12956/tchd.915322.
Vancouver
1.Müjdem Azılı, Hatice Germen Ünverdi, Sema Hücümenoğlu, Tuğrul Tiryaki. Can Testicular Fibrosis Due to Testicular Torsion Be Prevented with Ketotifen As A Mast Cell Stabilizer? Turkish J Pediatr Dis. 2021 May 1;15(3):234-8. doi:10.12956/tchd.915322


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.